Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials
Article in Journal of Allergy and Clinical Immunology (February 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Journal of Allergy and Clinical Immunology (February 2024)
Article in Journal of the European Academy of Dermatology and Venereology (September 2023)
Article in Dermatology and Therapy (June 2023)